The stock of Allscripts Healthcare Solutions (NASDAQ:MDRX) registered an increase of 4.76% in short interest. MDRX’s total short interest was 19.10 million shares in March as published by FINRA. Its up 4.76% from 18.23M shares, reported previously. With 2.55 million shares average volume, it will take short sellers 8 days to cover their MDRX’s short positions. The short interest to Allscripts Healthcare Solutions’s float is 10.82%. The stock increased 5.43% or $0.66 during the last trading session, hitting $12.81. Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) has declined 5.25% since August 21, 2015 and is downtrending. It has underperformed by 9.52% the S&P500.
Allscripts Healthcare Solutions, Inc. is engaged in engaged in delivering Information Technology and services. The company has a market cap of $2.41 billion. The Firm sells its solutions to physicians, hospitals, governments, health systems, health plans, retail clinics, retail pharmacies, pharmacy benefit managers and post-acute organizations, such as home health and hospice agencies. It currently has negative earnings. The Firm operates through three divisions: Clinical and Financial Solutions, Population Health, and Managed Services.
The institutional sentiment decreased to 1.28 in 2015 Q3. Its down 0.07, from 1.35 in 2015Q2. The ratio turned negative, as 29 funds sold all Allscripts Healthcare Solutions Inc shares owned while 69 reduced positions. 38 funds bought stakes while 87 increased positions. They now own 196.07 million shares or 11.64% less from 221.90 million shares in 2015Q2.
Glenhill Advisors Llc holds 10.05% of its portfolio in Allscripts Healthcare Solutions Inc for 10.34 million shares. Blue Harbour Group L.P. owns 14.42 million shares or 5.57% of their US portfolio. Moreover, Tamarack Capital Management Llc has 3.17% invested in the company for 2.15 million shares. The New York-based Breithorn Capital Management has invested 3.02% in the stock. Broadview Advisors Llc, a Wisconsin-based fund reported 1.13 million shares.
Out of 19 analysts covering Allscripts-Misys Healthcare (NASDAQ:MDRX), 11 rate it “Buy”, 0 “Sell”, while 14 “Hold”. This means 44% are positive. Allscripts-Misys Healthcare was the topic in 20 analyst reports since August 5, 2015 according to StockzIntelligence Inc.
Allscripts Healthcare Solutions Inc - Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with MarketBeat.com’s FREE daily email newsletter.
